Celltrion and LISCure Biosciences announce strategic collaboration to develop novel microbiome treatment for Parkinson's disease
- Written by PR Newswire
- Co-research and co-development of novel microbiome therapeutics
- Discovery of new candidates to meet high unmet medical needs in Parkinson's disease
SEOUL, South Korea, Feb. 20, 2023 /PRNewswire/ -- LISCure Biosciences Inc., a clinical-stage biotech developing advanced microbiome technology with precision targets, announced a multi-year...